<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">342541</id>
  <title nil="true"/>
  <common-name>3-(1-oxo-1-piperidin-1-ylpropan-2-yl)-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one</common-name>
  <description>3-(1-oxo-1-piperidin-1-ylpropan-2-yl)-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one is a chemical compound with the formula C25H29N3O5. It has an average molecular weight of 451.50 g/mol.</description>
  <cas>83409-02-3</cas>
  <pubchem-id>3068401</pubchem-id>
  <chemical-formula>C25H29N3O5</chemical-formula>
  <weight>451.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T03:30:58Z</created-at>
  <updated-at type="dateTime">2026-08-31T03:30:58Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(C(=O)N1CCCCC1)N2C(=NC3=CC=CC=C3C2=O)C4=CC(=C(C(=C4)OC)OC)OC</moldb-smiles>
  <moldb-formula>C25H29N3O5</moldb-formula>
  <moldb-inchi>InChI=1S/C25H29N3O5/c1-16(24(29)27-12-8-5-9-13-27)28-23(26-19-11-7-6-10-18(19)25(28)30)17-14-20(31-2)22(33-4)21(15-17)32-3/h6-7,10-11,14-16H,5,8-9,12-13H2,1-4H3</moldb-inchi>
  <moldb-inchikey>QHCBVYHTEAEPBR-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">451.210721</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM338434</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-(1-oxo-1-piperidin-1-ylpropan-2-yl)-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazanaphthalenes</klass>
  <subklass>Benzodiazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0292930</sync-id>
  <structure-inchikey>QHCBVYHTEAEPBR-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>60000000000000000000000000180001000000000000000000000000000000400000003040000020000400100000402004000000000000000000000000000080000000000000000000000000000100000020000000000100080000000000000000000100010000000044000200100000000000020100000000000000000000000800000040000000c04000000000000000800000000100000000000000000000000000000000000000040000080000000000000000010020008000000000000080000000040000010000000000000000400000000000002000000200000000000000000000000001000040000800000400000000000020000002004000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAhAAAAJAAAAIABBgBgAAAAAQMGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:42:09Z</structure-indexed-at>
</compound>
